Carbomer homopolymer type C

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Carbomer homopolymer type C
Accession Number
DB14091
Description

Carbomer homopolymer type C is a high molecular polyanionic substance tested for antiulcerogenic activity.

Type
Small Molecule
Groups
Experimental, Investigational
Synonyms
  • Acrypol 940
  • Carbomer 934P
  • Carbomer 980
  • Carbomer homopolymer type C (allyl pentaerythritol crosslinked)
  • Carbomer-940
  • Carbomer-980
  • Carbopol 980 polymer

Pharmacology

Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Purchasing individual compounds or compound libraries for your research?
Learn More
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
RRB PakCarbomer homopolymer type C (1 g/1g) + Betamethasone dipropionate (0.5 mg/1g)KitTopicalAlvix Laboratories, LLC2015-12-122019-01-30US flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
4Q93RCW27E
CAS number
57916-92-4

References

General References
Not Available
RxNav
1362909

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentCommon Cold1
1CompletedOtherCommon Cold1
1, 2CompletedTreatmentPruritus1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelOphthalmic2 mg/g
KitTopical
GelOphthalmic10 g
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on June 18, 2018 10:49 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates